Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021

SELL
$145.58 - $192.14 $420,143 - $554,516
-2,886 Closed
0 $0
Q2 2021

Jul 23, 2021

SELL
$134.22 - $202.37 $24,428 - $36,831
-182 Reduced 5.93%
2,886 $565,000
Q1 2021

May 03, 2021

BUY
$140.25 - $196.86 $83,168 - $116,737
593 Added 23.96%
3,068 $555,000
Q4 2020

Feb 02, 2021

BUY
$126.47 - $163.7 $52,105 - $67,444
412 Added 19.97%
2,475 $350,000
Q3 2020

Nov 12, 2020

BUY
$87.44 - $125.0 $180,388 - $257,875
2,063 New
2,063 $257,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track B & T Capital Management Dba Alpha Capital Management Portfolio

Follow B & T Capital Management Dba Alpha Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.